Lv5
944 积分 2022-10-21 加入
Efficacy and safety of first-line lorlatinib versus crizotinib in patients with advanced, ALK-positive non-small-cell lung cancer: updated analysis of data from the phase 3, randomised, open-label CROWN study
1天前
已完结
Garsorasib in patients with KRASG12C-mutated non-small-cell lung cancer in China: an open-label, multicentre, single-arm, phase 2 trial
14天前
已完结
Neurofibromatosis type 1 system-based manifestations and treatments: a review
14天前
已完结
Cutaneous manifestations in neurofibromatosis type 1
15天前
已关闭
[Neurofibromatosis type 1: recent advances]
15天前
已关闭
Targeting HER2 heterogeneity in breast and gastrointestinal cancers
30天前
已完结
Effects of purified eicosapentaenoic acid versus mixed eicosapentaenoic/docosahexaenoic acid pharmacotherapies on coronary plaque volume: network meta-analysis of prospective coronary imaging trials
1个月前
已关闭
Stabilizing effect of combined eicosapentaenoic acid and statin therapy on coronary thin-cap fibroatheroma
1个月前
已完结
Cholesterol, Atherosclerotic, and Inflammatory Risks Among Patients With Statin Therapy
1个月前
已完结
Prevalence of low-attenuation plaques and statin therapy in plaque rupture type of acute coronary syndrome
1个月前
已完结
皖公网安备34019202002308
